4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-000008
CEO bought 10,000 shares at $1.20 ($12,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna CEO | 2024-12-30 | Purchase | +10,000 | $1.20 | $12,000 | 137,553 | I |
| Open-market purchases · 10,000 sh · avg $1.20 · $12,000 | |||||||
Loading xslF345X05/primarydocument.xml…